Drugging ERK1/2 in Cancer: A Glimpse of Small-Molecule Inhibitors
{{output}}
The extracellular signal-regulated kinases 1 and 2 (ERK1/2) play central roles in the mitogen-activated protein kinase (MAPK) pathway and have emerged as critical regulators of tumorigenesis. Aberrant ERK1/2 signaling is frequently observed in cancers such as ... ...